Comprehensive Variant Effect Map of Parkin-Mediated Mitophagy in Parkinson’s Disease

preprint OA: closed CC-BY-NC-ND-4.0

Abstract

The development of Parkinson’s disease (PD) has a substantial genetic basis. Variants in the PRKN gene account for roughly half of autosomal-recessive PD cases, yet most variants remain classified as variants of uncertain significance. PRKN encodes the E3 ubiquitin-protein ligase, Parkin, that plays a key role in mitochondrial quality control by initiating mitophagy. In this work, we introduce a multiplexed mitophagy assay and measure the activity of more than 99% of all possible single–amino acid substitution and nonsense variants of Parkin. We also demonstrate that misfolded, rapidly degraded variants autonomously trigger Parkin-independent mitophagy. The obtained activity landscape closely reflects known structural and functional aspects of Parkin while revealing new insights into specific functional effects across the protein. This dataset near-perfectly distinguishes pathogenic from benign variants and surpasses both computational predictors and abundance-based metrics in pathogenicity assessment. Finally, the data pinpoint hypomorphic variants that could be amenable to rescue in future personalized therapeutic approaches for PD.
Full text 2,357 characters · extracted from oa-doi-fallback · click to expand
Abstract The development of Parkinson’s disease (PD) has a substantial genetic basis. Variants in the PRKN gene account for roughly half of autosomal-recessive PD cases, yet most variants remain classified as variants of uncertain significance. PRKN encodes the E3 ubiquitin-protein ligase, Parkin, that plays a key role in mitochondrial quality control by initiating mitophagy. In this work, we introduce a multiplexed mitophagy assay and measure the activity of more than 99% of all possible single–amino acid substitution and nonsense variants of Parkin. We also demonstrate that misfolded, rapidly degraded variants autonomously trigger Parkin-independent mitophagy. The obtained activity landscape closely reflects known structural and functional aspects of Parkin while revealing new insights into specific functional effects across the protein. This dataset near-perfectly distinguishes pathogenic from benign variants and surpasses both computational predictors and abundance-based metrics in pathogenicity assessment. Finally, the data pinpoint hypomorphic variants that could be amenable to rescue in future personalized therapeutic approaches for PD. Competing Interest Statement K.L.-L. holds stock options in, receives sponsored research from, and is a consultant for Peptone Ltd. The remaining authors have no relevant financial or non-financial interests to disclose. - Abbreviations - ACT - activation element - AO - antimycin and oligomycin - AM - AlphaMissense - ARPD - autosomal-recessive Parkinson’s disease - AUC - area under the curve - Baf - Bafilomycin - DMEM - Dulbecco’s modified Eagle medium - Dox - doxycycline - DUBTAC - deubiquitylating targeted chimeras - FACS - fluorescence-activated cell sorting - FBS - fetal bovine serum - IBR - in-between RING - IQR - interquartile range - IRES - internal ribosomal entry site - MAGIC - mitochondria as guardian in cytosol - MAVE - multiplexed assay of variant effects - MED - median - OMM - outer mitochondrial membrane - PAP - peptide abundance predictor - PD - Parkinson’s disease - REP - Repressor element - ROC - Receiver Operating Characteristic - SD - standard deviation - pUb - phospho-ubiquitin - pUBL - phospho-UBL - Ub - ubiquitin - UBL - ubiquitin-like - VAMP-seq - variant abundance by massively parallel sequencing - VUS - variant of unknown significance - WT - wild-type.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-22T02:00:06.705733+00:00
License: CC-BY-NC-ND-4.0